{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:38:34Z","timestamp":1782949114852,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100019214","name":"l\u00e9ka\u0159sk\u00e1 fakulta Univerzity Karlovy","doi-asserted-by":"publisher","award":["Cooperatio \u2013 Cardiovascular Science"],"award-info":[{"award-number":["Cooperatio \u2013 Cardiovascular Science"]}],"id":[{"id":"10.13039\/100019214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019214","name":"l\u00e9ka\u0159sk\u00e1 fakulta Univerzity Karlovy","doi-asserted-by":"publisher","award":["UNCE\/24\/MED\/015"],"award-info":[{"award-number":["UNCE\/24\/MED\/015"]}],"id":[{"id":"10.13039\/100019214","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40119-026-00444-w","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:13:59Z","timestamp":1769606039000},"page":"123-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Role of the PRECISE-DAPT Score in Acute Coronary Syndrome and Different Antithrombotic Treatment Strategies"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-8137","authenticated-orcid":false,"given":"D\u00e1vid","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Fojt\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojt\u011bch","family":"Berka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Ko\u010dka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radana","family":"Prachtov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Tou\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"10073","key":"444_CR1","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","volume":"389","author":"F Costa","year":"2017","unstructured":"Costa F, van Klaveren D, James S, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389(10073):1025\u201334.","journal-title":"Lancet"},{"issue":"7","key":"444_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jacc.2018.11.048","volume":"73","author":"F Costa","year":"2019","unstructured":"Costa F, Van Klaveren D, Feres F, et al. Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting. J Am Coll Cardiol. 2019;73(7):741\u201354.","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"444_CR3","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"5","key":"444_CR4","doi-asserted-by":"publisher","first-page":"e008530","DOI":"10.1161\/CIRCINTERVENTIONS.119.008530","volume":"13","author":"KH Choi","year":"2020","unstructured":"Choi KH, Bin SY, Lee JM, et al. Clinical usefulness of PRECISE-DAPT score for predicting bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2020;13(5):e008530.","journal-title":"Circ Cardiovasc Interv"},{"issue":"16","key":"444_CR5","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.4244\/EIJ-D-17-00550","volume":"13","author":"E Abu-Assi","year":"2018","unstructured":"Abu-Assi E, Raposeiras-Roubin S, Cobas-Paz R, et al. Assessing the performance of the PRECISE-DAPT and Paris risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients. EuroIntervention. 2018;13(16):1914\u201322.","journal-title":"EuroIntervention"},{"issue":"1","key":"444_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ehjcvp\/pvae060","volume":"11","author":"P Enstr\u00f6m","year":"2025","unstructured":"Enstr\u00f6m P, Martinsson A, Rezk M, et al. The four-item PRECISE-DAPT score identifies coronary artery bypass grafting patients with increased risk for post-discharge major bleeding. Eur Heart J Cardiovasc Pharmacother. 2025;11(1):48\u201356.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"444_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100552","volume":"29","author":"T Ando","year":"2020","unstructured":"Ando T, Nakazato K, Kimishima Y, et al. The clinical value of the PRECISE-DAPT score in predicting long-term prognosis in patients with acute myocardial infarction. IJC Heart Vasc. 2020;29:100552.","journal-title":"IJC Heart Vasc"},{"issue":"2","key":"444_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00592-021-01792-w","volume":"59","author":"F Garc\u00eda-Rodeja Arias","year":"2022","unstructured":"Garc\u00eda-Rodeja Arias F, \u00c1lvarez \u00c1lvarez B, Gonz\u00e1lez Ferrero T, et al. Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS? Acta Diabetol. 2022;59(2):163\u201370.","journal-title":"Acta Diabetol"},{"issue":"9","key":"444_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s12471-015-0727-0","volume":"23","author":"GJA Vos","year":"2015","unstructured":"Vos GJA, Bennaghmouch N, Qaderdan K, et al. Management of the patient with an acute coronary syndrome using oral anticoagulation. Neth Heart J. 2015;23(9):407.","journal-title":"Neth Heart J"},{"issue":"6","key":"444_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/CIRCULATIONAHA.118.036248","volume":"139","author":"N van Rein","year":"2019","unstructured":"van Rein N, Heide-J\u00f8rgensen U, Lijfering WM, et al. Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy: results from a Nationwide Danish Cohort Study. Circulation. 2019;139(6):775\u201386.","journal-title":"Circulation"},{"issue":"9872","key":"444_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","volume":"381","author":"WJM Dewilde","year":"2013","unstructured":"Dewilde WJM, Oirbans T, Verheugt FWA, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381(9872):1107\u201315.","journal-title":"Lancet"},{"key":"444_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartjsupp\/suac001","author":"P Tou\u0161ek","year":"2022","unstructured":"Tou\u0161ek P, Bauer D, Neuberg M, et al. Patient characteristics, treatment strategy, outcomes, and hospital costs of acute coronary syndrome: 3 years of data from a large high-volume centre in Central Europe. Eur Heart J Suppl. 2022. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suac001.","journal-title":"Eur Heart J Suppl"},{"key":"444_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39:119\u201377.","journal-title":"Eur Heart J"},{"key":"444_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa575","author":"J-P Collet","year":"2020","unstructured":"Collet J-P, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa575.","journal-title":"Eur Heart J"},{"issue":"5","key":"444_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1177\/0003319718807057","volume":"70","author":"VO Tanik","year":"2019","unstructured":"Tanik VO, Cinar T, Arugaslan E, et al. The predictive value of PRECISE-DAPT score for in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2019;70(5):440\u20137.","journal-title":"Angiology"},{"issue":"3","key":"444_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/ehjcvp\/pvaa135","volume":"8","author":"F Costa","year":"2022","unstructured":"Costa F, Valgimigli M, Steg PG, et al. Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. Eur Heart J Cardiovasc Pharmacother. 2022;8(3):216\u201326.","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-026-00444-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-026-00444-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-026-00444-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:26:22Z","timestamp":1773509182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-026-00444-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1007\/s40119-026-00444-w","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Petr Tousek reports consultant contract and lecture fees from Medtronic. Viktor Kocka reports consultant contract, lectures and advisory board contract from Medtronic and Phillips; lecture fees from Edwards Lifesciences. D\u00e1vid Bauer, Adam Fojt\u00edk, Vojt\u011bch Berka, Marek Neuberg and Radana Prachtov\u00e1 have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study complies with the Declaration of Helsinki. An acute coronary syndrome registry has been approved by the Faculty Hospital Kr\u00e1lovsk\u00e9 Vinohrady and the Third Faculty of Medicine Charles University ethics committee (No. EK-R\/01\/0\/2017, part of \"Interventional treatment of life-threatening cardiovascular diseases\" within the framework of the grant call OP VVV No. 02 16 026 \"Long-term intersectoral cooperation\"). The analyzed data were anonymized.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}